Green Genome India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.90 M
as on 15-12-2024
- Revenue -87.16%
(FY 2022)
- Profit -91.34%
(FY 2022)
- Ebitda -102.32%
(FY 2022)
- Net Worth 7.61%
(FY 2022)
- Total Assets 10.58%
(FY 2022)
About Green Genome India
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.90 M.
Simar Singh and Harbhajan Chhabra serve as directors at the Company.
- CIN/LLPIN
U51909DL2017PTC311107
- Company No.
311107
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Green Genome India Private Limited offer?
Green Genome India Private Limited offers a wide range of products and services, including Plastic & Glass Labware, Volumetric Pipette, Laboratory Bottles.
Who are the key members and board of directors at Green Genome India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Simar Singh  | Director | 27-Jan-2017 | Current |
| Harbhajan Chhabra | Director | 27-Jan-2017 | Current |
Financial Performance of Green Genome India.
Green Genome India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 87.16% decrease. The company also saw a substantial fall in profitability, with a 91.34% decrease in profit. The company's net worth moved up by a moderate rise of 7.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Green Genome India?
In 2020, Green Genome India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Green Genome Global Private LimitedActive 2 years 6 months
Simar Singh and Harbhajan Chhabra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Aug 2021 | ₹0.90 M | Open |
How Many Employees Work at Green Genome India?
Unlock and access historical data on people associated with Green Genome India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Green Genome India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Green Genome India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
